Integrated Study Results of Teprotumumab The First Drug US FDA Approved for the Treatment of Thyroid Eye Disease - NORD (National Organization for Rare Disorders)

Advanced Search

Home / News / Integrated Study Results of Teprotumumab The First Drug US FDA Approved for the Treatment of Thyroid Eye Disease

Sep. 30, 2020

TOPIC:

Integrated Study Results of Teprotumumab The First Drug US FDA Approved for the Treatment of Thyroid Eye Disease

Posted by Sean Roberts

Topics

Patients & Members

Alone we are rare. Together we are strong.®